About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Breast Cancer Clinical Trials in Houston | 1,199 Studies

Clinical Trials Breast CancerHouston

Breast Cancer Clinical Trials in Houston

Find 1,199 clinical trials for breast cancer near Houston, Texas. Connect with research centers in your area.

All Breast Cancer trials nationwide All trials in Houston

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 101-120 of 1,199 trials

TerminatedPrecision Performance Status Assessment in Breast Cancer Patients Receiving Neoadjuvant ChemotherapyThis study assesses the performance status in stage I-III triple negative breast cancer patients who are receiving neoadjuvant chemotherapy.NCT04835597·Houston, Texas RecruitingA Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF AlterationsThe objective of this Master Protocol is to evaluate the efficacy and safety of plixorafenib in participants with BRAF altered (BRAF V600E or BRAF fusions) locally advanced or…NCT05503797·Beverly Hills, California and 69 others

Breast Cancer Trials in Other Cities

New York Los Angeles Chicago Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

RecruitingPhase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal CancersThe purpose of this study is to evaluate the safety, tolerability, dosimetry and preliminary efficacy of \[177Lu\]Lu-NNS309 and the safety, dosimetry and imaging properties of…NCT06562192·Birmingham, Alabama and 28 others

CompletedHormone Receptor Positive Metastatic Breast Cancer (HR+ mBC) BIIB021 Plus Aromasin Schedule FindingThe purpose of this study is to assess the efficacy, safety and tolerability of 2 dosing regimens of BIIB021 in combination with exemestane in women whose HR+ breast cancer had…NCT01004081·Alabaster, Alabama and 33 others

RecruitingPhase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)This is a Phase 3, open-label, randomized, clinical trial evaluating the efficacy and safety of gedatolisib and palbociclib plus endocrine therapy for the treatment of patients…NCT06757634·Jonesboro, Arkansas and 238 others

SuspendedA Phase Ib Study of Novel Combination (New) of Low Dose Oral CyclophoSphamide (s) to Potentiate Axatilimab (A) + Retifanlimab (R) in Treating Metastatic Triple Negative Breast Cancer (TNBC)The goal of this clinical research study is to find the best dose of the drugs cyclophosphamide and axatilimab that can be given in combination with the standard dose of…NCT06959537·Houston, Texas

TerminatedMM-302 Plus Trastuzumab vs. Chemotherapy of Physician's Choice Plus Trastuzumab in HER2-Positive Locally Advanced/Metastatic Breast Cancer PatientsThis study is an open label, randomized, multicenter trial of MM-302 plus trastuzumab.NCT02213744·Glendale, Arizona and 108 others

CompletedLetrozole in Treating Postmenopausal Women With Ductal Carcinoma in SituRATIONALE: Estrogen can cause the growth of breast cancer cells.NCT01439711·Los Angeles, California and 31 others

Active not recruitingComparing an Operation to Monitoring, With or Without Endocrine Therapy (COMET) Trial For Low Risk DCISThis study looks at the risks and benefits of active monitoring (AM) compared to surgery in the setting of a pragmatic prospective randomized trial for low risk DCIS.NCT02926911·Anchorage, Alaska and 140 others

RecruitingA Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)Researchers are looking for other ways to treat breast cancer (BC) that is hormone receptor-positive and human epidermal growth factor receptor 2-negative (HR+/HER2-) and either…NCT07060807·Daphne, Alabama and 200 others

TerminatedStudy of CB-839 (Telaglenastat) in Combination With Talazoparib in Patients With Solid TumorsThis is a Phase 1b/2 study to determine the recommended phase 2 dose (RP2D), safety and tolerability, pharmacokinetics (PK) and clinical activity of the glutaminase inhibitor…NCT03875313·Birmingham, Alabama and 8 others

CompletedVaccine Therapy in Treating Patients With Breast CancerRATIONALE: Vaccines made from peptides may help the body build an effective immune response to kill tumor cells that express HER2/neu.NCT00524277·Washington D.C., District of Columbia and 12 others

TerminatedA Study of LY3435151 in Participants With Solid TumorsThe reason for this study is to see if the study drug LY3435151 is safe in participants with advanced solid tumors.NCT04099277·Houston, Texas and 1 other

TerminatedEfficacy Study of Dasatinib in Locally Advanced Triple-Negative Breast Cancer PatientsWe want to learn if dasatinib will make triple negative breast cancers smaller. We also hope that we can learn more about what makes triple negative breast cancers grow.NCT00817531·Houston, Texas

CompletedA Study to Evaluate Patient Preference and Satisfaction of Subcutaneous Administration of the Fixed-Dose Combination of Pertuzumab and Trastuzumab in Participants With HER2-Positive Early Breast CancerThis is a Phase II, randomized, multicentre, multinational, open-label, cross-over study in adult patients who have completed neoadjuvant chemotherapy with neoadjuvant pertuzumab…NCT03674112·Lakewood, Colorado and 39 others

CompletedEffects of Meditation on Cognitive Function and Quality of LifeThe goal of this research study is to test Tibetan meditation as a therapy to teach cancer patients to change their brain functioning and to improve quality of life.NCT02162329·Houston, Texas and 1 other

RecruitingOlaparib With Cediranib or AZD6738 for the Treatment of Advanced or Metastatic Germline BRCA Mutated Breast CancerThis phase II trial studies how well olaparib with cediranib or AZD6738 works in treating patients with germline BRCA mutated breast cancer that has spread to other places in the…NCT04090567·Houston, Texas

CompletedS0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone MetastasesRATIONALE: Gathering information about how often osteonecrosis of the jaw occurs in patients receiving zoledronic acid for bone metastases may help doctors learn more about the…NCT00874211·Anniston, Alabama and 452 others

Active not recruitingWeight Management and Health Behavior Intervention in Lowering Cancer Risk for BRCA Positive and Lynch Syndrome FamiliesThis trial studies how well weight management and health behavior intervention works in helping patients with hereditary breast and ovarian cancer and Lynch syndrome mutation…NCT04125914·Houston, Texas

RecruitingStudy of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid TumorsThis study will evaluate the safety, tolerability, and preliminary effectiveness of AMXT 1501 and DFMO when combined with standard treatments for advanced solid tumors.NCT07287917·Tucson, Arizona and 19 others

PreviousPage 6 of 60Next

Other Conditions in Houston

Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma